Trans Men and HIV
Trans persons face severe HIV-related challenges, with trans men gender diverse individuals assigned female at birth (AFAB) significantly overlooked in the global HIV response. Despite a significant need for specific responses, a persistent and often falls believe that trans men and AFAB gender diverse have a low risk of acquiring HIV has led to exclusion from critical health strategies. Emerging data and advocacy efforts aim to correct this disparity and foster inclusion.
In 2022, trans persons had the lowest global viral suppression rates (44%) among key populations and the highest HIV prevalence in most global regions, with figures reaching 39.4% in the Caribbean. Despite these alarming statistics, trans men and AFAB gender diverse persons remain excluded from the global HIV response, largely due to a belief in their low HIV risk. This exclusion is exacerbated by a lack of data and inconsistent population estimates. New findings indicate that trans men and AFAB individuals are almost seven times more likely to contract HIV than the general population.
The International Working Group on Transmasculine People and HIV, coordinated by GATE, emerged to address this gap. They aim to increase awareness among global health institutions and policymakers about the HIV risks faced by trans men and AFAB gender diverse persons. Their inclusive feminist approach stresses the need for more resources for both trans women and men as well as all gender diverse people. The group has produced vital advocacy tools, including the 2023 Trans Men in the Global HIV Response Policy Brief and Factsheet, to drive comprehensive inclusion in HIV response strategies, such as addressing Prevention and treatment of HIV as well as the unique experiences of transmasculine individuals.
Sandro Niederer, Project Manager Sexual Health of trans persons, Swiss AIDS Federation